drugset / Trial / NCT04524026

RIOTC: Reducing the Impact of Ovarian Stimulation. Novel Approaches to Luteal Support in IVF-Study 2

NCT04524026 ↗

RandomizedParallel-groupOpen-labelTreatment

Summary

The goal of the randomised controlled study (RCT) is to identify novel strategies that can improve the luteal phase endocrinology after ovarian stimulation, with the aim of using less or no luteal support in IVF while making the endometrium thinner and more receptive to embryo implantation.

Timeline

Start
2018-09-18
Primary completion
2020-11-30
Completion
2020-11-30

Outcome

Met primary endpoint

paper 8.0 (6.8-11.5) days compared with 5.0 (5.0-6.8) days in the intervention and control group, respectively (P < 0.001). PMID 35779242 ↗

Drugs

EvaluationDrugModalityDoseRoute
Subject Letrozole Other / unclassified 5 mg —

Indications

No indication recorded.